AFP and neoplasm: At present, the clinical diagnosis of intracranial GCTs relies on a combination of imaging characteristics and the presence of tumor markers, namely alpha-fetoprotein (AFP) and beta subunit of human chorionic gonadotropin (β-HCG), in the serum and/or cerebrospinal fluid (CSF).